A Study of TRK-170 for the Treatment of Crohn's Disease

• Status: Completed
• Trial end date: 2014-04-01
• Target enrollment: 0
• Participant gender: All

Summary

In Crohn's Disease Patients

• To evaluate the efficacy of TRK-170

• To evaluate the PK characteristics of TRK-170

• To assess the safety of TRK-170

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Toray Industries, Inc

Criteria

Inclusion Criteria:

• Patient has a diagnosis of Crohn's Disease before screening

• Patient has stable disease activity

Exclusion Criteria:

• Patient has had a clinically significant illness prior to screening

• Patient with clinically significant deviations in laboratory values